HIV/AIDS Clinical Trials in Houston

Showing 101-120 of 470 trials

Evaluating the Safety, Tolerability, and Effect of a Human Monoclonal Antibody (VRC01) on Markers of HIV Persistence in HIV-Infected Adults Receiving Antiretroviral Therapy (ART)

NCT02411539

The purpose of this study was to evaluate the safety, tolerability, and effect of an experimental human monoclonal antibody (mAb), VRC-HIVMAB060-00-AB (VRC01), in adults infected with HIV who were receiving antiretroviral therapy (ART).

HIV Infections

National Institute of Allergy and Infectious Diseases (NIAID)40 participantsStarted Aug 2015

San Diego, California, United States • Aurora, Colorado, United States • Chicago, Illinois, United States +10 more locations

COMPLETEDPhase 2< 1 mile

Safety of and Immune Response to a Novel Human Papillomavirus Vaccine in HIV Infected Children

NCT00339040

The purpose of this study is to determine the safety of and immune response to a new human papillomavirus (HPV) vaccine in HIV (Human immunodeficiency virus) infected children between the ages of 7 and 12 years.

HIV InfectionsSexually Transmitted Diseases

National Institute of Allergy and Infectious Diseases (NIAID)130 participantsStarted Oct 2006

Alhambra, California, United States • Long Beach, California, United States • Los Angeles, California, United States +31 more locations

Evaluating the Safety, Tolerability, and Effect of a Human Monoclonal Antibody (VRC01) on Markers of HIV Persistence in HIV-Infected Adults Receiving Antiretroviral Therapy (ART)

Safety of and Immune Response to a Novel Human Papillomavirus Vaccine in HIV Infected Children

HIV/AIDS Trials in Other Cities

Safety of and Immune Response to an H1N1 Influenza Vaccine in HIV Infected Pregnant Women

Atazanavir Used in Combination With Other Anti-HIV Drugs in HIV-Infected Infants, Children, and Adolescents

A Randomized, Comparative Trial of Zidovudine (AZT) Versus 2',3'-Didehydro-3'-Deoxythymidine (Stavudine; d4T) in Children With HIV Infection

Tactile Low Vision Labeling of Ophthalmic Drops

A Study of Three Treatment Combinations Using Zidovudine Plus Lamivudine Plus Indinavir in HIV-Infected Patients

Pharmacokinetic Study to Evaluate Double-Dose Levonorgestrel Emergency Contraception in Combination With Efavirenz-Based Antiretroviral Therapy or Rifampicin-Containing Anti-Tuberculosis Therapy

A Randomized, Comparative, Prospective Study of Daily Trimethoprim / Sulfamethoxazole (TMS) and Thrice-Weekly TMS for Prophylaxis Against PCP in HIV-Infected Patients

Evaluating the Safety and Pharmacokinetics of Maraviroc in HIV-1-Exposed Infants at Risk of Acquiring HIV-1 Infection

Evaluating the Safety and Pharmacokinetics of Raltegravir in Infants

Safety and Immune Response to Vicriviroc in Combination Regimens in HIV-Infected ART Experienced Children and Adolescents

Effects of a Uridine Supplement on HIV Infected Adults With Lipoatrophy

Antiviral Activity of and Resistance to Lamivudine in Combination With Zidovudine, Stavudine, or Didanosine

Thalidomide for Treatment of Oral and Esophageal Aphthous Ulcers and HIV Viremia in Patients With HIV Infection

A Phase I Concentration-Controlled Trial to Assess the Safety, Tolerance, Pharmacokinetics and Development of Decreased HIV-1 Susceptibility to the Combination of Atevirdine Mesylate (U-87201E), Zidovudine (AZT), and Didanosine (ddI)

The Safety and Effectiveness of Zidovudine in the Treatment of Patients With Early AIDS Related Complex

A Study of Three Anti-HIV Drug Combinations in Patients Who Have Taken Amprenavir

A Phase I Study of Safety and Pharmacokinetics of Nevirapine in HIV-1 Infected Pregnant Women and Neonates Born to HIV-1 Infected Mothers

Assessment of Pre-Exposure Prophylaxis (PrEP) Administered at Sexually Transmitted Disease (STD) Clinics

Other Conditions in Houston